New cancer clinical trial: BP-C1 Monotherapy in Patients With Metastatic Breast Cancer: Estimation of Optimal Duration of Treatment

Published on: December 28, 2018 at 12:00PM
Conditions:   Metastatic Breast Cancer;   Stage IV Breast Cancer
Intervention:   Drug: BP-C1
Sponsors:   Meabco A/S;   Meddoc;   Norwegian University of Life Sciences
Completed
http://bit.ly/2AmubdG